GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fabino Life Sciences Ltd (BOM:543444) » Definitions » EV-to-Revenue

Fabino Life Sciences (BOM:543444) EV-to-Revenue : 0.42 (As of May. 21, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Fabino Life Sciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Fabino Life Sciences's enterprise value is ₹64.5 Mil. Fabino Life Sciences's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was ₹151.8 Mil. Therefore, Fabino Life Sciences's EV-to-Revenue for today is 0.42.

The historical rank and industry rank for Fabino Life Sciences's EV-to-Revenue or its related term are showing as below:

BOM:543444' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.05   Med: 1.77   Max: 2.99
Current: 0.43

During the past 5 years, the highest EV-to-Revenue of Fabino Life Sciences was 2.99. The lowest was 1.05. And the median was 1.77.

BOM:543444's EV-to-Revenue is ranked better than
93.48% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 2.42 vs BOM:543444: 0.43

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-21), Fabino Life Sciences's stock price is ₹30.31. Fabino Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was ₹79.40. Therefore, Fabino Life Sciences's PS Ratio for today is 0.38.


Fabino Life Sciences EV-to-Revenue Historical Data

The historical data trend for Fabino Life Sciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fabino Life Sciences EV-to-Revenue Chart

Fabino Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
- - - 1.23 1.92

Fabino Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Sep22 Mar23 Sep23
EV-to-Revenue Get a 7-Day Free Trial - 1.23 - 1.92 -

Competitive Comparison of Fabino Life Sciences's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Life Sciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fabino Life Sciences's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fabino Life Sciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Fabino Life Sciences's EV-to-Revenue falls into.



Fabino Life Sciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Fabino Life Sciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=64.456/151.791
=0.42

Fabino Life Sciences's current Enterprise Value is ₹64.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fabino Life Sciences's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was ₹151.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fabino Life Sciences  (BOM:543444) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Fabino Life Sciences's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=30.31/79.4
=0.38

Fabino Life Sciences's share price for today is ₹30.31.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2023 was ₹79.40.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fabino Life Sciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Fabino Life Sciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Fabino Life Sciences (BOM:543444) Business Description

Traded in Other Exchanges
N/A
Address
Murthal Road,, Shubham Garden, Jeevan Vihar Extension Near, Sonipat, HR, IND, 131001
Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.

Fabino Life Sciences (BOM:543444) Headlines

No Headlines